Choline Niacin Composition for LDL Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for hyperlipidemia and weight loss, such as statin drugs, have significant side effects and are not entirely effective in addressing the underlying biological mechanisms, leading to a need for improved therapeutic options.
Innovation Solution
A pharmaceutical composition comprising choline, niacin, folic acid, methionine, and glycine, or their salts and esters, which are administered to treat hyperlipidemia, lower LDL cholesterol, and aid in weight reduction, potentially offering a safer and more effective alternative.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If statin drugs are used to treat hyperlipidemia, then LDL cholesterol levels are reduced, but significant side effects occur
Solution Approach 1:
The invention segments the treatment approach by using multiple individual nutrients (choline, niacin, folic acid, methionine, glycine) instead of a single statin drug. Each nutrient addresses different aspects of lipid metabolism and methylation pathways, collectively achieving LDL reduction while avoiding statin-related side effects through a divided therapeutic strategy.
Solution Approach 2:
The invention introduces methyl groups as intermediary substances that mediate the conversion of homocysteine to methionine and support phosphatidylcholine synthesis. This intermediary methylation process addresses the underlying metabolic defects causing hyperlipidemia without directly inhibiting HMG-CoA reductase, thereby avoiding statin side effects while achieving lipid normalization.
2Quantity of substance
If conventional treatments address hyperlipidemia symptoms, then cholesterol levels improve, but underlying biological mechanisms are not addressed
Solution Approach 1:
The invention performs preliminary action by providing充足的 methyl groups through choline, niacin, folic acid, methionine, and glycine before lipid metabolism defects can fully manifest. This preemptive methylation support prevents homocysteine accumulation and ensures proper phosphatidylcholine synthesis, addressing root causes before they lead to hyperlipidemia symptoms.
Solution Approach 2:
The invention enables self-service by providing the body with all necessary methyl donors and precursors needed for endogenous phosphatidylcholine synthesis and homocysteine metabolism. The nutrients work together to restore the body's natural methylation capacity, allowing self-correction of metabolic defects without requiring continuous external intervention.
Data Source
AI summary
Compositions and methods for treating hyperlipidemia and elevated LDL cholesterol and for reduction are disclosed. The compositions comprise (a) choline, or a salt or hydroxide thereof; (b) niacin, or a salt, amide or ester thereof; (c) folic acid, or a salt thereof; (d) methionine or a salt or ester thereof; and (e) glycine or a salt, ester or methylated form thereof.